Linked Data API

Show Search Form

Search Results

1045911
registered interest false more like this
date less than 2019-01-22more like thismore than 2019-01-22
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Continuing Care remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many people received continuing health care in each Care Commission Group; and the cost of that care in each of the last five years. more like this
tabling member constituency Sheffield South East remove filter
tabling member printed
Mr Clive Betts more like this
uin 211100 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-28more like thismore than 2019-01-28
answer text <p>A table showing the number of cases found eligible for NHS Continuing Healthcare (CHC) during the years from 2013-14 to 2017-18 is attached. The table refers to the clinical commissioning groups (CCGs) at that time; the total is for both standard and fast track NHS CHC.</p><p> </p><p>Tables showing CCG total NHS CHC expenditure by year, 2013-14 to 2017-18 is attached. Due to different number of weeks paid for in a care package, it is not possible to calculate an average package cost. Activity and cost data cannot therefore be used to approximate cost per person.</p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
attachment
1
file name PQ211100 Annex B cost of CHC by CCG.xlsx more like this
title PQ211100 attached table more like this
2
file name PQ211100 Annex A Number eligible by CCG format.xlsx more like this
title PQ211100 attached table more like this
question first answered
less than 2019-01-28T14:37:07.313Zmore like thismore than 2019-01-28T14:37:07.313Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
394
label Biography information for Mr Clive Betts more like this
60637
registered interest false more like this
date less than 2014-06-09more like thismore than 2014-06-09
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Continuing Care remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to ensure that the Clinical Priorities Advisory Group takes account of evidence from (a) patients, (b) clinicians and (c) patient groups when making decisions on the availability of treatments for progressive conditions. more like this
tabling member constituency Sheffield South East remove filter
tabling member printed
Mr Clive Betts more like this
uin 199558 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-06-16more like thismore than 2014-06-16
answer text <p>NHS England has advised that the Clinical Priorities Advisory Group (CPAG) is an advisory group and not a decision making body. It considers policy and makes recommendations to the Directly Commissioned Services Committee who make the final decisions on NHS England's commissioning position.</p><p> </p><p>The Group's membership includes four Patient and Public Voice members and senior clinicians from NHS England. The policies that are presented to CPAG for consideration are developed by Clinical Reference Groups (CRGs) who are made up of patients, clinicians, and key stakeholders including patient groups. These members are involved in the development of policies.</p><p> </p><p>Prior to submission of any documents to CPAG, a two week stakeholder testing phase is undertaken where registered CRG stakeholders including clinicians, patients, and patient groups, as well as industry, have an opportunity to make comments. These are considered as well as the evidence base for the policy by CPAG.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2014-06-16T14:32:45.2063762Zmore like thismore than 2014-06-16T14:32:45.2063762Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
394
label Biography information for Mr Clive Betts more like this